Abstract
Objective
Bone marrow oedema (BMO) is a multifactorial condition. The conservative treatment options include immobilisation of the affected region and systemic intravenous iloprost therapy. Whereas many studies confirm the positive effect of iloprost therapy in larger joints, e.g. knee and hip, there have been few studies of BMO in smaller areas such as the ankle joint or midfoot. The purpose of this study is to show that treatment with iloprost leads to positive long-term outcomes for BMO of the foot and ankle.
Methods
Twenty-three patients with BMO of the ankle joint or midfoot, Association Research Circulation Osseous (ARCO) stages 1–2, were included in this study. A questionnaire was used to record the Ankle–hindfoot, Kaikkonen, SF-36 and VAS scores before and after iloprost therapy. In addition, all patients underwent MRI for radiological follow-up monitoring 3 months after treatment.
Results
A significant improvement in function based on the ankle–hindfoot and Kaikkonen scale was demonstrated after iloprost therapy. In 22 patients, follow-up MRI after 3 months showed complete regression of the oedema.
Conclusion
Based on the positive results of our study, we recommend treatment with iloprost for BMO of the upper ankle joint and foot at ARCO stages 1–2.
Similar content being viewed by others
References
Craiovan BS, Baier C, Grifka J, Götz J, Schaumburger J, Beckmann J (2013) Bone marrow edema syndrome (BMES). Orthopäde 42(3):191–204. doi:10.1007/s00132-012-2053-1
Doury P (1994) Bone-marrow oedema, transient osteoporosis, and algodystrophy. J Bone Joint Surg (Br) 76(6):993–994
Aigner N, Petje G, Schneider W, Krasny C, Grill F, Landsiedl S (2002) Juvenile bone-marrow oedema of the acetabulum treated by iloprost. J Bone Joint Surg (Br) 84(7):1050–1052. doi:10.1302/0301-620X.84B7.13175
Jäger M, Tillmann FP, Thornhill TS, Mahmoudi M, Blondin D, Hetzel GR, Zilkens C, Krauspe R (2008) Rationale for prostaglandin I2 in bone marrow oedema-from theory to application. Arthr Res Ther 10(5):R120. doi:10.1186/ar2526
Orth P, Anagnostakos K (2013) Coagulation abnormalities in osteonecrosis and bone marrow edema syndrome. Orthopedics 36(4):290–300. doi:10.3928/01477447-20130327-08
Poll LW, Willers R, Häussinger D, Mödder U, von Dahl S (2010) MRI bone marrow findings in 63 patients with type I Gaucher disease. Rofo 182(11):979–985. doi:10.1055/s-0029-1245410
Fernandez-Canton G (2009) From bone marrow edema to osteonecrosis. New concepts. Reumatol Clin 5(5):223–227. doi:10.1016/j.reuma.2008.02.004
Disch AC, Matziolis G, Perka C (2005) The management of necrosis-associated and idiopathic bone-marrow oedema of the proximal femur by intravenous iloprost. J Bone Joint Surg (Br) 87(4):560–564. doi:10.1302/0301-620X.87B4.15658
Mayerhoefer ME, Kramer J, Breitenseher MJ, Norden C, Vakil-Adli A, Hofmann S, Meizer R, Siedentop H, Landsiedl F, Aigner N (2007) Short-term outcome of painful bone marrow oedema of the knee following oral treatment with iloprost or tramadol: results of an exploratory phase II study of 41 patients. Rheumatology 46(9):1460–1465. doi:10.1093/rheumatology/kem172
Hofmann S, Engel A, Neuhold A, Leder K, Kramer J, Plenk H Jr (1993) Bone-marrow edema syndrome and transient osteoporosis of the hip: an MRI-controlled study of treatment by core decompression. J Bone Joint Surg (Br) 75(2):210–216
Vande Berg B, Lecouvet F, Koutaïssoff S, Simoni P, Maldague B, Malghem J (2011) Transient bone marrow edema of the hip. J Radiol 92(6):557–566. doi:10.1016/j.jradio.2011.05.002
Steinbach LS, Suh KJ (2011) Bone marrow edema pattern around the knee on magnetic resonance imaging excluding acute traumatic lesions. Semin Musculoskelet Radiol 15(3):208. doi:10.1055/s-0031-1278421
Beckmann J, Schmidt T, Schaumburger J, Rath B, Lüring C, Tingart M, Grifka J (2013) Infusion, core decompression, or infusion following core decompression in the treatment of bone edema syndrome and early avascular osteonecrosis of the femoral head. Rheumatol Int 33(6):1561–1565. doi:10.1007/s00296-012-2597-8
Aigner N, Meier R, Stolz G, Petje G, Krasny C, Landsiedl F, Steinboeck G (2003) Iloprost for the treatment of bone marrow edema of the hindfoot. Foot Ankle Clin 8(4):683–693. doi:10.1016/S1083-7515%2803%2900145-1
Aigner N, Petje G, Steinboeck G, Schneider W, Krasny C, Landsiedl F (2001) Treatment of bone marrow oedema of the talus with the prostacyclin analogue iloprost. J Bone Joint Surg (Br) 83(6):855–858. doi:10.1302/0301-620X.83B6.11377
Aigner N, Radda C, Meizer R, Petje G, Kotsaris S (2005) Bone marrow edema in the foot—MRI findings after conservative therapy. Foot Ankle Surg 11:87–91. doi:10.1016/j.fas.2005.01.003
Arazi M, Yel M, Uguz B, Emlik D (2006) Be aware of bone marrow edema syndrome in ankle arthroscopy: a case successfully treated with iloprost. Arthroscopy 22(6):909.e1–909.e3. doi:10.1016/j.arthro.2006.05.011
Baier C, Schaumburger J, Götz J, Heers G, Schmidt T, Grifka J, Beckmann J (2013) Bisphosphonates or prostacyclin in the treatment of bone-marrow oedema syndrome of the knee and foot. Rheumatol Int 33(6):1397–1402. doi:10.1007/s00296-012-2584-0
Krug S, Sablotzki A, Hammerschmidt S, Wirtz H, Seyfarth HJ (2009) Inhaled iloprost for the control of pulmonary hypertension. Vasc Health Risk Manage 5(1):465–474. doi:10.2147/VHRM.S3223
Buckley MS, Staib RL, Wicks LM (2013) Combination therapy in the management of pulmonary arterial hypertension. Int J Clin Pract Suppl 179:13–23. doi:10.1111/ijcp.12136
Kawald A, Burmester GR, Huscher D, Sunderkötter C, Riemekasten G (2008) Low versus high-dose iloprost therapy over 21 days in patients with secondary Raynaud’s Phenomenon and Systemic Sclerosis. J Rheumatol 35(9):1830–1837
Noël B, Panizzon RG (2004) Use of duplex ultrasonography in the treatment of thromboangiitis obliterans with iloprost. Dermatology 208(3):238–240. doi:10.1159/000077309
Gardeniers JW (1992) A new international classification of osteonecrosis of the ARCO-committee on terminology and classification. ARCO News 4:41–46
Bartl C, Imhoff A, Bartl R (2012) Treatment of bone marrow edema syndrome with intravenous ibandronate. Arch Orthop Trauma Surg 132(12):1781–1788. doi:10.1007/s00402-012-1617
Meizer R, Radda C, Stolz G, Kostaris S, Petje G, Kransy C, Wilk M, Mayerhöfer M, Landsiedl F, Aigner N (2005) MRI-controlled analysis of 104 patients with painful bone marrow edema indifferent joint localization treated with the prostacyclin analogue iloprost. Wien Klin Wochenschr 117:278–286. doi:10.1007/s00508-005-0326-y
Conflict of interest
We did not receive any benefits directly or indirectly from commercial parties.
Author information
Authors and Affiliations
Corresponding author
Additional information
Eric Röhner and Timo Zippelius contributed equally to this work.
Rights and permissions
About this article
Cite this article
Röhner, E., Zippelius, T., Steindl, D. et al. Effects of intravenous iloprost therapy in patients with bone marrow oedema of the foot and ankle. Eur J Orthop Surg Traumatol 24, 1609–1616 (2014). https://doi.org/10.1007/s00590-013-1320-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00590-013-1320-0